IN8bio Inc Stock price
Is IN8bio Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
IN8bio Inc Stock Analysis
Analyst Opinions
10 Analysts have issued a IN8bio Inc forecast:
Analyst Opinions
10 Analysts have issued a IN8bio Inc forecast:
Don't miss a Thing! We will send you all news about IN8bio Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
IN8bio Inc Stock News
Company Profile
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
| Head office | United States |
| CEO | Mr. Ho |
| Employees | 17 |
| Founded | 2016 |
| Website | www.in8bio.com |


